Home LiteratureArticle Details
PMID: 24002181 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Heparin blocks transfer of extracellular vesicles between donor and recipient cells.

Journal of neuro-oncology ·Vol. 115 ·No. 3 ·2013-12-00 ·Pages 343-51

Atai NA, Balaj L, van Veen H, Breakefield XO, Jarzyna PA, Van Noorden CJ, Skog J, Maguire CA

Abstract

Extracellular vesicles (EVs) have been implicated in tumorigenesis. Biomolecules which can block EV binding and uptake into recipient cells may be of therapeutic value as well as enhance understanding of EV biology. Here, we show that heparin interacts with uptake of tumor-derived as well as non-tumor-derived EVs into recipient cells. Incubation of glioma cell-derived EVs with heparin resulted in micron-sized structures observed by transmission electron microscopy, with EVs clearly visible within these structures. Inclusion of heparin greatly diminished transfer of labeled EVs from donor to recipient tumor cells. We also show a direct interaction between heparin and EVs using confocal microscopy. We found that the block in EV uptake was at the level of cell binding and not internalization. Finally, incubation of glioma-derived EVs containing EGFRvIII mRNA with heparin reduced transfer of this message to recipient cells. The effect of heparin on EVs uptake may provide a unique tool to study EV function. It may also foster research of heparin or its derivatives as a therapeutic for disease in which EVs play a role.

MeSH Terms
Anticoagulants/pharmacology ErbB Receptors/genetics,metabolism Extracellular Space/drug effects Flow Cytometry Glioblastoma/drug therapy,metabolism,pathology Heparin/pharmacology Humans RNA, Messenger/genetics Real-Time Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction Transport Vesicles/drug effects Tumor Cells, Cultured
Chemicals
Anticoagulants RNA, Messenger epidermal growth factor receptor VIII Heparin ErbB Receptors
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Atai Nadia A
Department of Neurology and Program in Neuroscience, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
Balaj Leonora
van Veen Henk
Breakefield Xandra O
Jarzyna Peter A
Van Noorden Cornelis J F
Skog Johan
Maguire Casey A
References (28)
28 references, click to expand
  1. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
    Nat Cell Biol. 2008 Dec;10(12):1470-6 PMID: 19011622
  2. Exosomes: composition, biogenesis and function.
    Nat Rev Immunol. 2002 Aug;2(8):569-79 PMID: 12154376
  3. Inhibition of metastases by anticoagulants.
    J Natl Cancer Inst. 1999 Jan 6;91(1):22-36 PMID: 9890167
  4. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
    Cancer Res. 2007 Aug 1;67(15):7458-66 PMID: 17671216
  5. Isolation and identification of histone H3 protein enriched in microvesicles secreted from cultured sebocytes.
    Endocrinology. 2005 Jun;146(6):2593-601 PMID: 15746254
  6. Clinical studies with anticoagulants to improve survival in cancer patients.
    Pathophysiol Haemost Thromb. 2008;36(3-4):204-11 PMID: 19176993
  7. Microvesicle-associated AAV vector as a novel gene delivery system.
    Mol Ther. 2012 May;20(5):960-71 PMID: 22314290
  8. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.
    Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3352-7 PMID: 11248082
  9. Preventing growth of brain tumors by creating a zone of resistance.
    Mol Ther. 2008 Oct;16(10):1695-702 PMID: 18714312
  10. Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles.
    Immunol Res. 2006;36(1-3):247-54 PMID: 17337785
  11. Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group.
    Cancer. 1994 Jul 1;74(1):38-45 PMID: 8004580
  12. Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates?
    Braz J Med Biol Res. 1999 May;32(5):529-38 PMID: 10412563
  13. Microvesicles: messengers and mediators of tumor progression.
    Cell Cycle. 2009 Jul 1;8(13):2014-8 PMID: 19535896
  14. Mechanisms of heparin induced anti-cancer activity in experimental cancer models.
    Crit Rev Oncol Hematol. 2007 Mar;61(3):195-207 PMID: 17074500
  15. Experimental and clinical effects of anticoagulants on cancer progression.
    Thromb Res. 2010 Apr;125 Suppl 2:S77-9 PMID: 20434011
  16. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.
    Nat Cell Biol. 2012 Jun 03;14(7):677-85 PMID: 22660413
  17. The effects of unfractionated heparin on survival in patients with malignancy--a systematic review.
    Thromb Haemost. 1999 Dec;82(6):1600-4 PMID: 10613641
  18. Functional delivery of viral miRNAs via exosomes.
    Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6328-33 PMID: 20304794
  19. Management of venous thromboembolism.
    N Engl J Med. 1996 Dec 12;335(24):1816-28 PMID: 8943165
  20. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.
    Nat Commun. 2011 Feb 01;2:180 PMID: 21285958
  21. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.
    Neuro Oncol. 2012 Nov;14 Suppl 5:v1-49 PMID: 23095881
  22. The potential of exosomes in immunotherapy.
    Expert Opin Biol Ther. 2005 Jun;5(6):737-47 PMID: 15952905
  23. Suppression of membrane microvesiculation--a possible anticoagulant and anti-tumor progression effect of heparin.
    Blood Cells Mol Dis. 2009 May-Jun;42(3):223-7 PMID: 19261492
  24. Actions of heparin that may affect the malignant process.
    Cancer. 1999 Jan 15;85(2):257-72 PMID: 10023691
  25. The use of heparin for treating human malignancies.
    Haemostasis. 1999 Dec;29 Suppl S1:48-60 PMID: 10629404
  26. Heparin and cancer.
    Thromb Haemost. 1998 Jul;80(1):10-23 PMID: 9684778
  27. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.
    Thromb Haemost. 1999 Aug;82(2):947-52 PMID: 10605808
  28. Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.
    Eur J Cancer. 1997 Jul;33(8):1209-15 PMID: 9301444
Article Info
Journal
Journal of neuro-oncology
Abbr.
J Neurooncol
ISSN
1573-7373
Published
2013-12-00
Epub
2013-00-04
Pages
343-51
Language
English
Region
United States
NLM ID
8309335
PMCID
PMC3856724
Subset
IM
Grants
NCI NIH HHS · R21 CA141226 · United States
NCI NIH HHS · P01 CA069246 · United States
NINDS NIH HHS · P30 NS045776 · United States
NINDS NIH HHS · R21 NS081374 · United States
NCI NIH HHS · CA141150 · United States
NCI NIH HHS · CA156009 · United States
NCI NIH HHS · R01 CA141150 · United States
NINDS NIH HHS · P30NS045776 · United States
NCI NIH HHS · R21 CA156009 · United States
NCI NIH HHS · CA069246 · United States
NCI NIH HHS · CA141226 · United States
NINDS NIH HHS · 1 R21 NS081374-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com